Eureka Health operates an AI-powered platform and community that lets chronic disease patients share real-world treatment experiences, search a treatment database, and connect with similar patients in a private space. The company emerged from stealth with thousands already engaged in its Long Covid group and has opened communities for metabolic disease, autoimmune disorders, and ME/CFS, with more conditions being added weekly. Eureka uses large language models to build a database of millions of patient experiences, interpret and summarize research, match similar patients, and generate personalized treatment predictions; it plans to offer patients an AI assistant. Patients retain full control over their data and can remain anonymous if they choose. The platform’s product roadmap emphasizes expanding condition-specific communities and growing its treatment database to inform future research and treatment discovery. Eureka’s founding team combines personal experience with chronic disease and technical/product expertise to guide development. The company raised funding to accelerate community growth and product development.

Total raised

$7M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2023